# US 6,727,235 B2 · Synergistic compositions for the selective control of tumor tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,235 B2
- Document ID: US6727235B2
- Status: Granted
- Kind: B2
- Application number: 10/371,088
- Filed: 2003-02-21
- Published: 2003-09-04
- Granted: 2004-04-27
- Earliest claimed: 1997-06-24
- Inventors: Werner Kreutz
- Web page: https://patentgrep.com/patent/US6727235B2

## CPC

- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/195: having an amino group
- A61K 31/60: Salicylic acid; Derivatives thereof
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

According to the invention, compositions are made available which have a strong cytotoxic effect which is largely selective on tumor tissue. The invention is based on the fact that certain benzoic acid derivatives have a strong synergistic effect as a mixture and destroy cancer cells selectively in a pH range of 7 or below, such as from 6.5 to 7.

## Claims

### Claim 1

Method of treating cancer sensitive to the synergistic composition of 5-(2,4-difluorophenyl)salicyclic acid in combination with acetylsalicyclic acid or salicyclic acid, comprising the step of administering to a patient in need thereof a pharmaceutically effective amount of said synergistic composition.

### Claim 2 (depends on 1)

Method of treating cancer sensitive to the synergistic composition of claim 1, wherein said cancer is a carcinomatose disorder.

### Claim 3 (depends on 1)

Method of treating cancer sensitive to the synergistic composition of claim 1, wherein said composition is administered in a pharmaceutically tolerable excipient.

### Claim 4

Synergistic composition comprising 5-(2,4-difluorophenyl)salicyclic acid in combination with acetylsalicyclic acid or salicyclic acid.

### Claim 5

Medicament comprising a synergistic composition comprising 5-(2,4-difluorophenyl)salicyclic acid in combination with salicyclic acid or acetylsalicyclic acid and a pharmaceutically tolerable excipient.
